Interestingly, IL-1β may promote tumorigenesis and tumor invasion (13), and the blockade of the IL-1 receptor by an IL-1R antagonist was shown to improve the anti-tumor effect of chemotherapy (14, 15). Here, IL1R1 is linked to neoplasm.